Circadian disruption in cancer hallmarks: Novel insight into the molecular mechanisms of tumorigenesis and cancer treatment

Autor: Zhou, Zhaokai, Zhang, Ruiqi, Zhang, Yuyuan, Xu, Yudi, Wang, Ruizhi, Chen, Shuang, Lv, Yingying, Chen, Yifeng, Ren, Yuqing, Luo, Peng, Cheng, Quan, Xu, Hui, Weng, Siyuan, Zuo, Anning, Ba, Yuhao, Liu, Shutong, Han, Xinwei, Liu, Zaoqu

Publikováno v: In Cancer Letters 1 November 2024 604

Molecular subtypes of ischemic heart disease based on circadian rhythm.

Autor: Zhou, Zhaokai^1,2 (AUTHOR), Zhang, Ge³ (AUTHOR), Wang, Zhan² (AUTHOR), Xu, Yudi⁴ (AUTHOR), Qin, Hongzhuo⁴ (AUTHOR), Zhang, Haonan⁵ (AUTHOR), Zhang, Pengpeng⁶ (AUTHOR), Li, Zhengrui⁷ (AUTHOR), Xu, Shuai^8,9 (AUTHOR), Tan, Xin^8,9 (AUTHOR), Zeng, Yiyao^8,9 (AUTHOR), Yu, Fengyi³ (AUTHOR), Zhu, Shanshan¹⁰ (AUTHOR), Chang, Le¹¹ (AUTHOR), Zheng, Youyang¹² (AUTHOR), Han, Xinwei^1,13,14 (AUTHOR) fcchanxw@zzu.edu.cn

Publikováno v: Scientific Reports. 6/19/2024, Vol. 14 Issue 1, p1-13. 13p.

Proteomics appending a complementary dimension to precision oncotherapy

Autor: Zhou, Zhaokai, Zhang, Ruiqi, Zhou, Aoyang, Lv, Jinxiang, Chen, Shuang, Zou, Haijiao, Zhang, Ge, Lin, Ting, Wang, Zhan, Zhang, Yuyuan, Weng, Siyuan, Han, Xinwei, Liu, Zaoqu

Publikováno v: In Computational and Structural Biotechnology Journal December 2024 23:1725-1739

The underlying mechanism of chimeric antigen receptor (CAR)-T cell therapy triggering secondary T-cell cancers: Mystery of the Sphinx?

Autor: Zhou, Zhaokai, Zhang, Ge, Xu, Yudi, Yang, Shuai, Wang, Jiaojiao, Li, Zhengrui, Peng, Fu, Lu, Qiong

Publikováno v: In Cancer Letters 10 August 2024 597

Eravacycline improves the efficacy of anti-PD1 immunotherapy via AP1/CCL5 mediated M1 macrophage polarization in melanoma

Autor: Liu, Nian, Yan, Mingjie, Lu, Can, Tao, Qian, Wu, Jie, Zhou, Zhaokai, Chen, Jing, Chen, Xiang, Peng, Cong

Publikováno v: In Biomaterials March 2025 314